| A Trial of YPEG-rhGH in Children With Short Stature (NCT05838885) | Xiamen Amoytop Biotech Co., Ltd. | 2022-02-15 |
| Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature (NCT04798690) | Dong-A ST Co., Ltd. | 2021-02-08 |
| Skeletal Muscle Effects of GH in Boys (NCT04020913) | Nemours Children's Clinic | 2019-07-22 |
| Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF) (NCT01438801) | Ipsen | 2013-05-01 |
| Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature (NCT01778023) | Novo Nordisk A/S | 2013-01-17 |
| A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS) (NCT01746862) | Merck KGaA, Darmstadt, Germany | 2012-12-01 |
| Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature (NCT01786902) | Dong-A ST Co., Ltd. | 2012-02-01 |
| Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children (NCT01604395) | LG Chem | 2012-01-01 |
| Short Stature Related Distress (NCT01246219) | Rabin Medical Center | 2011-10-01 |
| Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers (NCT01401244) | Novo Nordisk A/S | 2011-07-14 |
| Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature (NCT01248416) | Nemours Children's Clinic | 2010-11-01 |
| Pharmacodynamics of CNP During Growth Hormone Treatment (NCT01504802) | Nemours Children's Clinic | 2010-11-01 |
| Genotropin Study Assessing Use of Injection Pen (NCT00965484) | Pfizer | 2009-10-01 |
| Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study) (NCT00710307) | Ipsen | 2008-10-01 |
| Ghrelin Levels in Children With Poor Growth (NCT01070173) | Tripler Army Medical Center | 2008-01-01 |
| A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height (NCT00840944) | Belgian Study Group for Pediatric Endocrinology | 2008-01-01 |
| Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature (NCT00396097) | Pfizer | 2006-12-01 |
| Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature (NCT00458263) | Rabin Medical Center | 2006-04-01 |
| Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin (NCT00488124) | University of Erlangen-Nürnberg Medical School | 2005-11-01 |
| Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature (NCT00121875) | Massachusetts General Hospital | 2005-06-01 |
| Constructing an Insulin-Like Growth Factor-based Prediction Model (NCT00263445) | University of California, Los Angeles | 2004-08-01 |
| Safety and Efficacy of Long-term Somatropin Treatment in Children (NCT01543867) | Novo Nordisk A/S | 2001-01-01 |
| Effect of Growth Hormone in Children With Growth Hormone Deficiency (NCT00262249) | Novo Nordisk A/S | 2000-08-01 |